PT - JOURNAL ARTICLE AU - Hua, Jianian AU - Dong, Jianye AU - Shen, Yueping TI - Trends in Cognitive Function Pre- and Post- Stroke: Finding from the China Health and Retirement Longitudinal Study AID - 10.1101/2021.09.24.21263136 DP - 2021 Jan 01 TA - medRxiv PG - 2021.09.24.21263136 4099 - http://medrxiv.org/content/early/2021/12/15/2021.09.24.21263136.short 4100 - http://medrxiv.org/content/early/2021/12/15/2021.09.24.21263136.full AB - Introduction The magnitude of changes in cognitive function after stroke among the Chinese population is not clear. We aimed to learn the trajectories of cognitive function before and after incident stroke among Chinese participants.Methods Data were obtained from a nationally representative study. A total of 13311 Chinese participants aged 45 years or older and without a history of stroke were assessed at baseline between June 2011 and March 2012 and in at least one cognitive test between Wave 2 to Wave 4. Cognitive function was assessed by a global cognition score, which included episodic memory, visuospatial abilities, and executive function. A linear mixed model was developed to explore the repeated measurements.Results During the seven-year follow-up, we observed 610 (4.6%) participants experienced the first stroke. The baseline mean (SD) age was 58.6 (9.2) years. 47.3% of them were male. There was no difference in the baseline cognitive function and decline rate of pre-stroke cognition between stroke survivors and stroke-free participants after adjusting for covariates. Among the stroke survivors, the acute decline was -0.123, -0.169, and -0.135 SD/y in cognitive domains of episodic memory, visuospatial ability, and global cognition, respectively. The executive function did not decline acutely after stroke. In the years following stroke, the decline rate of executive function was 0.056 SD/y faster than the rate before stroke. The decline rate of episodic memory, visuospatial ability, and global cognition did not accelerate after stroke.Conclusion Before stroke onset, the cognitive function of Chinese stroke survivors was similar to that of stroke-free participants. Incident stroke was associated with acute decline in global cognition, episodic memory, and visuospatial abilities, and accelerated decline in orientation, attention, and calculation abilities. The cognitive trajectories revealed by our study highlights the need to care for the cognitive decline among Chinese stroke survivors.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the National Natural Science Foundation of China (project number 81973143) and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethical approval for all the CHARLS waves was granted from the Institutional Review Board at Peking University. The IRB approval number for the main household survey, including anthropometrics, is IRB00001052-11015; the IRB approval number for biomarker collection is IRB00001052-11014. During the fieldwork, each respondent who agreed to participate in the survey was asked to sign two copies of informed consent; one copy was kept in the CHARLS office, which was also scanned and saved in PDF format. Four separate consents were obtained: one for the main fieldwork, one for the non-blood biomarkers and one for the taking of the blood samples, and another for storage of blood for future analyses.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data used in this manuscript were obtained from the CHARLS. Prof. Yaohui Zhao (National School of Development of Peking University), John Strauss (University of Southern California), and Gonghuan Yang (Chinese Center for Disease Control and Prevention) are the principal investigators.